Randomized Phase III Trial of Xcytrin (Motexafin Gadolinium) Injection for the treatment of Brain Metastases in Patients with Non-Small Cell Lung Cancer undergoing Whole Brain Radiation Therapy
Protocol Status:
Closed
Protocol Number:
J0304
Type of Cancer:
Brain Metastases (Non-Small Cell Lung Cancer)
Principal Investigator:
Lawrence Kleinberg, M.D.
Phase Number:
III
Summary:
The trial was closed to accrual on 01/25/06. 3 patients were enrolled on study and completed treatment. No serious adverse events were reported.
